Advantis secures 700K euros in seed funding

By staff writers

March 18, 2019 -- Image processing software developer Advantis Medical Imaging has received a seed investment of 700,000 euros from venture capital firm Metavallon VC, according to an 18 March article on

Advantis recently received the CE Mark for its Brainance MD software, a cloud-based platform that allows for the visualization and postprocessing of three types of brain MRI exams: diffusion-tensor imaging, dynamic susceptibility contrast perfusion, and functional MRI.

The investment will support promotional and commercial operations, the integration of artificial intelligence (AI) into its existing software services, and further research and development, according to Advantis.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking